Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Fall;20(4):466-72.
doi: 10.1176/jnp.2008.20.4.466.

Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion"

Affiliations

Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion"

Jason Brandt et al. J Neuropsychiatry Clin Neurosci. 2008 Fall.

Abstract

The authors examined whether the baseline cognitive functioning of 21 clinically normal huntingtin mutation carriers who developed manifest Huntington's disease on follow-up differed from that of 49 mutation carriers who remain asymptomatic over the same period in a longitudinal study. One hundred thirty-four gene-negative offspring of Huntington's disease patients were studied as well. Overall, there were no differences in cognitive test performance among the three groups. However, "converters" who developed signs of Huntington's disease within 8.6 years demonstrated poorer performance on the Wisconsin Card Sorting Test at baseline. People with the Huntington's disease mutation who are carefully examined neurologically and found to be asymptomatic have, at most, very minimal problem-solving impairment, and only if they are within a few years of clinical onset.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1. Wisconsin Card Sorting Test Results for Huntington’s Disease Early Converters, Late Converters, and Nonconverters
Left: Inefficiency scores for patients who developed symptoms within 8.62 years (early), after 8.62 years (late), and those who remained asymptomatic. For subjects who achieved no sorts, the denominator is set at 0.5 to allow computation of this summary score. Higher scores indicate worse performance. Means+SE. Right: Number of perseverative and nonperseverative errors.

References

    1. The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993;72:971–983. - PubMed
    1. Aylward EH, Sparks BF, Field KM, et al. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology. 2004;63:66–72. - PubMed
    1. Rosas HD, Hevelone ND, Zaleta AK, et al. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology. 2005;65:745–747. - PubMed
    1. Paulsen JS, Zimbelman JL, Hinton SC, et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington’s disease. Am J Neuroradiol. 2004;25:1715–1721. - PMC - PubMed
    1. Reading S, Dziorny AC, Peroutka LA, et al. Functional brain changes in presymptomatic Huntington’s disease. Ann Neurol. 2004;55:879–883. - PubMed

Publication types